Government through the ministry of education has adjusted tuition fee for for generic undergraduate students at Kamuzu University of Healthy Sciences (KUHeS) to
27.10.2023 - Positive topline data reported in July from TREK-AD, a Phase 2b study of eblasakimab in moderate-to-severe atopic dermatitis, met the primary endpoint across three dosing arms; the study established eblasakimab’s potential to deliver a monthly .